Rock Springs Capital Management LP Vaxcyte, Inc. Transaction History
Rock Springs Capital Management LP
- $1.5 Billion
- Q3 2025
A detailed history of Rock Springs Capital Management LP transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 11,100 shares of PCVX stock, worth $536,574. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,100
Previous 11,100
-0.0%
Holding current value
$536,574
Previous $360,000
10.83%
% of portfolio
0.03%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
321Shares Held
134MCall Options Held
408KPut Options Held
116K-
Janus Henderson Group PLC London, X013.1MShares$633 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$596 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA12MShares$578 Million7.4% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$480 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.32MShares$402 Million0.18% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.87B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...